4
Changes in Ownership
Bolt Biotherapeutics, Inc. Filed Acc 0001209191-23-056185
Director sold 49,173 shares at an average $0.93 ($45,675)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ENGLEMAN EDGAR Director | 2023-11-16 | Sale | −7,531 | $0.96 | $7,230 | 1,989,685 | I: show line 1 in the form |
| ENGLEMAN EDGAR Director | 2023-11-17 | Sale | −8,211 | $0.93 | $7,636 | 1,981,474 | I: show line 2 in the form |
| ENGLEMAN EDGAR Director | 2023-11-20 | Sale | −27,465 | $0.92 | $25,268 | 1,954,009 | I: show line 3 in the form |
| ENGLEMAN EDGAR Director | 2023-11-16 | Sale | −1,040 | $0.96 | $998 | 274,749 | I: show line 4 in the form |
| ENGLEMAN EDGAR Director | 2023-11-17 | Sale | −1,134 | $0.93 | $1,055 | 273,615 | I: show line 5 in the form |
| ENGLEMAN EDGAR Director | 2023-11-20 | Sale | −3,792 | $0.92 | $3,489 | 269,823 | I: show line 6 in the form |
| Open-market sales · 49,173 sh · avg $0.93 · $45,675 | |||||||
Loading xslF345X05/doc4.xml…